Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
A completed laboratory study investigating early tumor markers in the peripheral blood of glioblastoma multiforme patients (with healthy vol…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CMV-specific cytotoxic T cells in patients with glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial assessing dietary, herbal, and alternative medicine in glioblastoma multiforme has been terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating CCI-779 in patients with recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating vorinostat for progressive or recurrent glioblastoma multiforme has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated Boron Neutron Capture Therapy in patients with glioblastoma multiforme or melanoma brain metastases; th…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse [Phase 2]
Completed Phase 2 trial evaluating Gefitinib (ZD 1839) for glioblastoma multiforme at first relapse.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study of AEE788 in combination with everolimus for patients with recurrent or relapsed gli…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial of erlotinib in recurrent glioblastoma multiforme or gliosarcoma was terminated. Results were posted in May 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 1, Phase 2]
This document reports the completed Phase 1/2 trial investigating motexafin gadolinium in combination with temozolomide and radiation therap…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating CYT-997 in combination with carboplatin for glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with irinotecan or temozolomide for recurrent or refractory glioblastoma multiforme or gliosar…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas [Phase 1]
A completed Phase 1 study evaluating XL765 in combination with temozolomide with or without radiation in adults with malignant gliomas.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme [Phase 2]
This clinical trial update summarizes a completed Phase 2 study examining cellular adoptive immunotherapy in patients with glioblastoma mult…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer [Phase 1, Phase 2]
Pfizer conducted a Phase 1/2 trial of bosutinib plus capecitabine in multiple solid tumors, including advanced breast cancer and pancreatic …
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) [Phase 2]
A phase 2 trial evaluating Gliadel implants followed by bevacizumab (Avastin) and irinotecan for glioblastoma multiforme was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma [Phase 3]
A Phase 3 trial evaluating radiotherapy with Carmustine, with or without O6-benzylguanine, in newly diagnosed glioblastoma multiforme or gli…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating oxaliplatin for newly diagnosed glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme [Phase 2]
Phase 2 trial in glioblastoma multiforme evaluating radiation therapy and temozolomide followed by temozolomide plus sorafenib. Results were…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating a combination of radiation therapy, temozolomide, and erlotinib for newly diagnosed glioblastoma multiform…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma [Phase 2]
Phase IIa safety and light-dose escalation trial in patients with primary or recurrent high-grade glioma using the Litx System to define the…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy followed by bone marrow or peripheral stem cell transplantation for glioblastoma multiforme…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors [Phase 2]
Phase 2 trial evaluating Tarceva, Temodar, and radiation therapy in newly diagnosed brain tumors (glioblastoma multiforme and gliosarcoma) c…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase II feasibility study of dendritic cell vaccination for newly diagnosed glioblastoma multiforme completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 study of Nitrocamptothecin in glioblastoma multiforme has completed.